Newport Pharmaceuticals Names UCI Dean to Board
Dr. Edward Quilligan, dean of the California College of Medicine at UC Irvine and vice chancellor for health sciences at the university, has been appointed to a new seat on the board of directors of Newport Pharmaceuticals Inc., a Newport Beach drug maker and distributor.
In accepting the appointment, Quilligan said that one of his principal goals is to “increase cooperation between the university and the business community.”
J. Roberts Fosberg, president and chief executive of Newport Pharmaceuticals, said that Quilligan’s national reputation as a health-care strategist and administrator would help the company as it grows and diversifies.
In addition to his roles at UCI, Quilligan is editor of “The American Journal of Obstetrics and Gynecology” and was named a fellow of England’s Royal College of Obstetricians and Gynecologists this year.
Since 1957, Quilligan has served in varied senior academic positions, including associate vice president for health affairs at USC.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
